Feng L, Yang S, Lin Y, Li J, Cao Z, Zheng Q
Pediatr Radiol. 2024; 54(6):954-964.
PMID: 38613691
DOI: 10.1007/s00247-024-05921-9.
Zhao Z, Yang C
Clin Exp Metastasis. 2024; 41(5):627-638.
PMID: 38609536
DOI: 10.1007/s10585-024-10286-2.
Piccardo A, Treglia G, Fiz F, Bar-Sever Z, Bottoni G, Biassoni L
Eur J Nucl Med Mol Imaging. 2023; 51(3):756-767.
PMID: 37962616
PMC: 10796700.
DOI: 10.1007/s00259-023-06486-9.
Rossor T, Yeh E, Khakoo Y, Angelini P, Hemingway C, Irani S
Neurol Neuroimmunol Neuroinflamm. 2022; 9(3).
PMID: 35260471
PMC: 8906188.
DOI: 10.1212/NXI.0000000000001153.
Quinones A, Vieira L, Wang J
Drug Metab Dispos. 2022; 50(9).
PMID: 35197314
PMC: 9488973.
DOI: 10.1124/dmd.121.000707.
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.
Samim A, Tytgat G, Bleeker G, Wenker S, Chatalic K, Poot A
J Pers Med. 2021; 11(4).
PMID: 33916640
PMC: 8066332.
DOI: 10.3390/jpm11040270.
I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.
Kitamura Y, Baba S, Isoda T, Maruoka Y, Sasaki M, Kamitani T
Ann Nucl Med. 2021; 35(5):549-556.
PMID: 33586098
PMC: 8079305.
DOI: 10.1007/s12149-021-01595-7.
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
Barr E, Laurie K, Wroblewski K, Applebaum M, Cohn S
Pediatr Blood Cancer. 2020; 67(10):e28390.
PMID: 32710697
PMC: 7722196.
DOI: 10.1002/pbc.28390.
MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders.
Rubio P, Galan V, Rodado S, Plaza D, Martinez L
Front Med (Lausanne). 2020; 7:173.
PMID: 32549040
PMC: 7270400.
DOI: 10.3389/fmed.2020.00173.
Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
Storz C, Bares R, Ebinger M, Handgretinger R, Tsiflikas I, Schafer J
BMC Med Imaging. 2019; 19(1):70.
PMID: 31429709
PMC: 6701085.
DOI: 10.1186/s12880-019-0372-y.
Guidelines on nuclear medicine imaging in neuroblastoma.
Bar-Sever Z, Biassoni L, Shulkin B, Kong G, Hofman M, Lopci E
Eur J Nucl Med Mol Imaging. 2018; 45(11):2009-2024.
PMID: 29938300
DOI: 10.1007/s00259-018-4070-8.
Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
Xia J, Zhang H, Hu Q, Liu S, Zhang L, Zhang A
J Huazhong Univ Sci Technolog Med Sci. 2017; 37(5):649-660.
PMID: 29058276
DOI: 10.1007/s11596-017-1785-x.
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Dubois S, Mody R, Naranjo A, Van Ryn C, Russ D, Oldridge D
Pediatr Blood Cancer. 2017; 64(11).
PMID: 28383813
PMC: 5605392.
DOI: 10.1002/pbc.26545.
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G, Tytgat G, Adam J, Caron H, Kremer L, Hooft L
Cochrane Database Syst Rev. 2015; (9):CD009263.
PMID: 26417712
PMC: 4621955.
DOI: 10.1002/14651858.CD009263.pub2.
2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.
Freebody J, Wegner E, Rossleigh M
World J Radiol. 2014; 6(10):741-55.
PMID: 25349660
PMC: 4209422.
DOI: 10.4329/wjr.v6.i10.741.
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.
Fendler W, Melzer H, Walz C, von Schweinitz D, Coppenrath E, Schmid I
Eur J Nucl Med Mol Imaging. 2013; 40(11):1701-10.
PMID: 23857458
DOI: 10.1007/s00259-013-2491-y.
Nuclear medicine and multimodality imaging of pediatric neuroblastoma.
Mueller W, Coppenrath E, Pfluger T
Pediatr Radiol. 2012; 43(4):418-27.
PMID: 23151727
DOI: 10.1007/s00247-012-2512-1.
Congenital tumors: imaging when life just begins.
Alamo L, Beck-Popovic M, Gudinchet F, Meuli R
Insights Imaging. 2012; 2(3):297-308.
PMID: 22347954
PMC: 3259397.
DOI: 10.1007/s13244-011-0073-8.
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V
Eur J Nucl Med Mol Imaging. 2011; 39(1):57-71.
PMID: 21932116
DOI: 10.1007/s00259-011-1938-2.
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Melzer H, Coppenrath E, Schmid I, Albert M, von Schweinitz D, Tudball C
Eur J Nucl Med Mol Imaging. 2011; 38(9):1648-58.
PMID: 21617976
DOI: 10.1007/s00259-011-1843-8.
